RTA Laboratuvarlari Biyolojik (RTALB) — Capital Reinvestment Ratio
RTA Laboratuvarlari Biyolojik (RTALB) has a Capital Reinvestment Ratio of 0.13x as of June 2025, meaning it reinvests 0% of its operating cash flow (TL20.98 Million) in capital expenditures (TL2.68 Million). See RTA Laboratuvarlari Biyolojik balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
RTA Laboratuvarlari Biyolojik Capital Reinvestment Ratio (2010–2023)
This chart tracks RTA Laboratuvarlari Biyolojik's Capital Reinvestment Ratio across 12 annual periods. Check RTA Laboratuvarlari Biyolojik (RTALB) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for RTA Laboratuvarlari Biyolojik (2010–2023)
Year-by-year Capital Reinvestment Ratio for RTA Laboratuvarlari Biyolojik from 2010 to 2023. For live market cap and broader valuation context, see how much is RTA Laboratuvarlari Biyolojik worth.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.67x | TL72.41 Million | TL48.48 Million | ▲ +114.8% |
| 2021 | 0.31x | TL68.78 Million | TL21.43 Million | ▼ -81.7% |
| 2020 | 1.70x | TL9.37 Million | TL15.96 Million | ▲ +17.4% |
| 2019 | 1.45x | TL3.58 Million | TL5.19 Million | ▲ +540.2% |
| 2017 | 0.23x | TL1.41 Million | TL318.64K | ▼ -73.2% |
| 2016 | 0.85x | TL2.86 Million | TL2.42 Million | ▲ +213.5% |
| 2015 | 0.27x | TL6.18 Million | TL1.67 Million | ▲ +9.1% |
| 2014 | 0.25x | TL2.58 Million | TL640.00K | ▼ -70.8% |
| 2013 | 0.85x | TL11.26 Million | TL9.56 Million | ▼ -9.3% |
| 2012 | 0.94x | TL2.24 Million | TL2.09 Million | ▲ +349.9% |
| 2011 | 0.21x | TL1.61 Million | TL335.00K | ▲ +6.7% |
| 2010 | 0.19x | TL2.78 Million | TL541.00K | — |